These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34892211)

  • 1. Modeling the Dynamics of a Secondary Neurodegenerative Injury Following a Mild Traumatic Brain Injury.
    Kochis RM; Ahota A; Garcia HB; Gottlieb RZ; Ruelas EB; Cauwenberghs G
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():4469-4472. PubMed ID: 34892211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traumatic Brain Injury in Children: Glial fibrillary Acidic Protein and Clinical Outcomes.
    Ryan E; Kelly L; Stacey C; Duff E; Huggard D; Leonard A; Boran G; McCollum D; Doherty D; Bolger T; Molloy EJ
    Pediatr Emerg Care; 2022 Mar; 38(3):e1139-e1142. PubMed ID: 34469402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study - "the PreTBI I study".
    Seidenfaden SC; Kjerulff JL; Juul N; Kirkegaard H; Møller MF; Münster AB; Bøtker MT
    Scand J Trauma Resusc Emerg Med; 2021 Jun; 29(1):75. PubMed ID: 34078435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid β up to 90 Days after Traumatic Brain Injury.
    Bogoslovsky T; Wilson D; Chen Y; Hanlon D; Gill J; Jeromin A; Song L; Moore C; Gong Y; Kenney K; Diaz-Arrastia R
    J Neurotrauma; 2017 Jan; 34(1):66-73. PubMed ID: 27312416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed increases in microvascular pathology after experimental traumatic brain injury are associated with prolonged inflammation, blood-brain barrier disruption, and progressive white matter damage.
    Glushakova OY; Johnson D; Hayes RL
    J Neurotrauma; 2014 Jul; 31(13):1180-93. PubMed ID: 24564198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GFAP-BDP as an acute diagnostic marker in traumatic brain injury: results from the prospective transforming research and clinical knowledge in traumatic brain injury study.
    Okonkwo DO; Yue JK; Puccio AM; Panczykowski DM; Inoue T; McMahon PJ; Sorani MD; Yuh EL; Lingsma HF; Maas AI; Valadka AB; Manley GT;
    J Neurotrauma; 2013 Sep; 30(17):1490-7. PubMed ID: 23489259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Anti-Glial Fibrillary Acidic Protein Autoantibody Levels during the Acute and Chronic Phases of Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study.
    Wang KK; Yang Z; Yue JK; Zhang Z; Winkler EA; Puccio AM; Diaz-Arrastia R; Lingsma HF; Yuh EL; Mukherjee P; Valadka AB; Gordon WA; Okonkwo DO; Manley GT; Cooper SR; Dams-O'Connor K; Hricik AJ; Inoue T; Maas AI; Menon DK; Schnyer DM; Sinha TK; Vassar MJ
    J Neurotrauma; 2016 Jul; 33(13):1270-7. PubMed ID: 26560343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A literature review of the feasibility of glial fibrillary acidic protein as a biomarker for stroke and traumatic brain injury.
    Schiff L; Hadker N; Weiser S; Rausch C
    Mol Diagn Ther; 2012 Apr; 16(2):79-92. PubMed ID: 22497529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study.
    Czeiter E; Amrein K; Gravesteijn BY; Lecky F; Menon DK; Mondello S; Newcombe VFJ; Richter S; Steyerberg EW; Vyvere TV; Verheyden J; Xu H; Yang Z; Maas AIR; Wang KKW; Büki A;
    EBioMedicine; 2020 Jun; 56():102785. PubMed ID: 32464528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NRGN, S100B and GFAP levels are significantly increased in patients with structural lesions resulting from mild traumatic brain injuries.
    Çevik S; Özgenç MM; Güneyk A; Evran Ş; Akkaya E; Çalış F; Katar S; Soyalp C; Hanımoğlu H; Kaynar MY
    Clin Neurol Neurosurg; 2019 Aug; 183():105380. PubMed ID: 31234132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel, sensitive translational immunoassay to detect plasma glial fibrillary acidic protein (GFAP) after murine traumatic brain injury.
    Button EB; Cheng WH; Barron C; Cheung H; Bashir A; Cooper J; Gill J; Stukas S; Baron DC; Robert J; Rowe EM; Cripton PA; Wellington CL
    Alzheimers Res Ther; 2021 Mar; 13(1):58. PubMed ID: 33678186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanical disruption of the blood-brain barrier following experimental concussion.
    Johnson VE; Weber MT; Xiao R; Cullen DK; Meaney DF; Stewart W; Smith DH
    Acta Neuropathol; 2018 May; 135(5):711-726. PubMed ID: 29460006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate traumatic brain injury increases the vulnerability to neurotoxicity induced by systemic administration of 6-hydroxydopamine in mice.
    de Oliveira PA; Ben J; Matheus FC; Schwarzbold ML; Moreira ELG; Rial D; Walz R; Prediger RD
    Brain Res; 2017 May; 1663():78-86. PubMed ID: 28288867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging.
    McMahon PJ; Panczykowski DM; Yue JK; Puccio AM; Inoue T; Sorani MD; Lingsma HF; Maas AI; Valadka AB; Yuh EL; Mukherjee P; Manley GT; Okonkwo DO;
    J Neurotrauma; 2015 Apr; 32(8):527-33. PubMed ID: 25264814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Diagnostic Competence of Glial Fibrillary Acidic Protein in Mild Traumatic Brain Injury and Its Prognostic Value in Patient Recovery.
    Forouzan A; Barzegari H; Hosseini O; Delirrooyfard A
    Turk Neurosurg; 2021; 31(3):355-360. PubMed ID: 33978198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury.
    Mondello S; Kobeissy F; Vestri A; Hayes RL; Kochanek PM; Berger RP
    Sci Rep; 2016 Jun; 6():28203. PubMed ID: 27319802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Caspase-3-Mediated Apoptosis in Chronic Caspase-3-Cleaved Tau Accumulation and Blood-Brain Barrier Damage in the Corpus Callosum after Traumatic Brain Injury in Rats.
    Glushakova OY; Glushakov AO; Borlongan CV; Valadka AB; Hayes RL; Glushakov AV
    J Neurotrauma; 2018 Jan; 35(1):157-173. PubMed ID: 28637381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-Related Differences in Diagnostic Accuracy of Plasma Glial Fibrillary Acidic Protein and Tau for Identifying Acute Intracranial Trauma on Computed Tomography: A TRACK-TBI Study.
    Gardner RC; Rubenstein R; Wang KKW; Korley FK; Yue JK; Yuh EL; Mukherje P; Valadka AB; Okonkwo DO; Diaz-Arrastia R; Manley GT
    J Neurotrauma; 2018 Oct; 35(20):2341-2350. PubMed ID: 29717620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.
    Diaz-Arrastia R; Wang KK; Papa L; Sorani MD; Yue JK; Puccio AM; McMahon PJ; Inoue T; Yuh EL; Lingsma HF; Maas AI; Valadka AB; Okonkwo DO; Manley GT;
    J Neurotrauma; 2014 Jan; 31(1):19-25. PubMed ID: 23865516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.
    Robinson S; Winer JL; Berkner J; Chan LA; Denson JL; Maxwell JR; Yang Y; Sillerud LO; Tasker RC; Meehan WP; Mannix R; Jantzie LL
    J Neurosurg Pediatr; 2016 Jun; 17(6):739-55. PubMed ID: 26894518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.